Delivery Order SPE2DB24D1201-SPE2DB25FJCKV
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml syringes, a medication used for various medical conditions. The contract has a ceiling value of $10,074.28 and is a firm fixed-price delivery order with a completion date of May 19, 2025. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Dupixent 300 mg/2 ml syringes, a medication used for various medical conditions. The contract has a ceiling value of $34,360.18 and is a firm fixed-price, non-set-aside contract with a completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a medication used to treat certain medical conditions. The contract has a ceiling value of $1,709.46 and is a firm fixed-price, non-set-aside award with a completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a specialty medication used for various medical treatments. The contract has a ceiling value of $10,778.02 and a period of performance through January 17, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a specialty medication used for various medical conditions. The contract has a ceiling value of $11,359.40 and a completion date of May 24, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,171.98 and an ultimate completion date of July 8, 2024. It is for the supply of Dupixent 300 mg/2 ml syringes, a specialty medication used for various medical conditions. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 200 mg/1.14 ml syringes. The contract has a ceiling value of $13,675.68 and an ultimate completion date of June 27, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml syringes, a prescription medication, with a ceiling value of $10,350.00 and a period of performance through April 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The contract has a ceiling value of $32,461.16 and a period of performance through April 28, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,298.23, is for the supply of Dupixent 300 mg/2 ml syringes, a prescription medication. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJCKVDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a medication used to treat certain medical conditions. The order has a ceiling value of $5,743.39 and is a firm fixed-price contract. The order is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 4/25/25 |